June 11, 2025
(Reuters) -Novavax’s experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in adults aged 65 and older, similar to already approved shots against […]
June 10, 2025
Health organizations and professional societies are expressing outrage over the firing of all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP). Robert F. […]
June 10, 2025
TOPLINE: The novel oral polio vaccine type 2 (nOPV2) induced intestinal mucosal immune responses comparable to those induced by the traditional Sabin monovalent oral polio vaccine […]
June 9, 2025
TOPLINE: Time to positivity, defined as the interval between blood culture incubation and the detection of pathogen growth, demonstrated a non-linear relationship with disease severity in […]
June 9, 2025
Malaria parasites can hide in people’s bodies for years or even decades without causing symptoms by shutting down the genes that make them visible to the […]
June 6, 2025
It didn’t smell as bad as I thought it would. Sort of like going-bad ocean water but without the salt. It doesn’t look as nasty as […]
June 3, 2025
The FDA has approved Moderna’s new COVID-19 shot, an mRNA vaccine, with some limits on who can get it. The vaccine, called mNexspike, is for people […]
June 3, 2025
TOPLINE: A novel multicomponent messenger RNA (mRNA) vaccine, mRNA-1083, demonstrated noninferiority to standard influenza and COVID-19 vaccines in adults aged 50 years or older, eliciting higher […]
June 2, 2025
TOPLINE: The quadrivalent recombinant influenza vaccine (RIV4) demonstrated non-inferior immune responses in children and adolescents aged 9-17 years compared with adults aged 18-49 years, with the […]